2170 studies found for:    Pulmonary Disease, Chronic Obstructive
Show Display Options
Rank Status Study
21 Recruiting Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Conditions: Lung Diseases, Obstructive;   Pulmonary Disease, Chronic Obstructive;   Bronchitis, Chronic
Intervention: Device: Yamax Digi-Walker CW-700
22 Completed
Has Results
A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: 125/25 mcg once-daily;   Drug: 125mcg once-daily;   Drug: Placebo once-daily
23 Completed
Has Results
A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: ADVAIR DISKUS™ 250/50mcg;   Other: Placebo
24 Completed A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
25 Completed
Has Results
Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: AZD1236;   Drug: Placebo
26 Completed Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate;   Drug: Formoterol Fumarate
27 Completed
Has Results
The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol 300 μg;   Drug: Placebo
28 Active, not recruiting Metformin in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Metformin;   Drug: Placebo
29 Completed
Has Results
A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GW685698/GW642444
30 Recruiting An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: JNJ 49095397;   Drug: Placebo
31 Completed
Has Results
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: ADVAIR DISKUS 250/50 mg BID;   Drug: SEREVENT 50 mcg BID
32 Completed PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Pulmonary Emphysema;   Chronic Bronchitis
Interventions: Drug: PROCHYMAL™;   Drug: Placebo
33 Completed
Has Results
Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: aclidinium bromide
34 Completed
Has Results
A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in Japan
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Symbicort Turbuhaler (Budesonide/formoterol);   Drug: Drug: any available COPD treatment; investigator to decide
35 Completed
Has Results
Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium bromide;   Drug: Placebo
36 Completed
Has Results
Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: AZD4818;   Drug: Placebo
37 Completed
Has Results
Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Combivent CFC-MDI;   Drug: Combivent Respimat 20/100 mcg;   Drug: Atrovent HFA 42 mcg + Albuterol HFA 200 mcg
38 Completed
Has Results
Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Aclidinium bromide
39 Active, not recruiting Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Emphysema;   Bronchitis, Chronic
Intervention:
40 Completed A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Airway Disease
Interventions: Drug: GW856553;   Drug: Placebo;   Drug: Seretide

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years